KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Assets (2016 - 2025)

Historic Assets for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $110.9 billion.

  • Novartis Ag's Assets rose 851.18% to $110.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $110.9 billion, marking a year-over-year increase of 851.18%. This contributed to the annual value of $110.9 billion for FY2025, which is 851.18% up from last year.
  • As of Q4 2025, Novartis Ag's Assets stood at $110.9 billion, which was up 851.18% from $107.3 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Assets ranged from a high of $131.8 billion in Q4 2021 and a low of $94.3 billion during Q1 2024
  • In the last 5 years, Novartis Ag's Assets had a median value of $111.6 billion in 2023 and averaged $111.9 billion.
  • In the last 5 years, Novartis Ag's Assets plummeted by 1595.41% in 2024 and then surged by 851.18% in 2025.
  • Novartis Ag's Assets (Quarter) stood at $131.8 billion in 2021, then fell by 10.88% to $117.5 billion in 2022, then decreased by 14.91% to $99.9 billion in 2023, then grew by 2.3% to $102.2 billion in 2024, then increased by 8.51% to $110.9 billion in 2025.
  • Its Assets was $110.9 billion in Q4 2025, compared to $107.3 billion in Q3 2025 and $104.4 billion in Q2 2025.